These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26101555)

  • 1. Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapy.
    Mateo A; Abadía B; Calvo P; Minguez E; Pablo L; Del Castillo JM
    J Ophthalmic Inflamm Infect; 2015; 5():18. PubMed ID: 26101555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent acanthamoeba and Fusarium keratitis with silicone hydrogel contact lens use.
    Lee B; Grossniklaus HE; Edelhauser HF
    Cornea; 2010 Feb; 29(2):210-3. PubMed ID: 20023585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection with Acanthamoeba and Pseudomonas in contact lens-associated keratitis.
    Sharma R; Jhanji V; Satpathy G; Sharma N; Khokhar S; Agarwal T
    Optom Vis Sci; 2013 Feb; 90(2):e53-5. PubMed ID: 23334312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Acanthamoeba keratitis in Synergeyes contact lens wear: clinical and confocal microscopy findings.
    Lee WB; Gotay A
    Eye Contact Lens; 2010 May; 36(3):164-9. PubMed ID: 20386314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of spontaneous corneal perforation secondary to undiagnosed Sjögren's syndrome using regenerating agent and autologous serum eye drops.
    Tzamalis A; Matsou A; Anastasopoulos E; Ziakas N
    Eur J Ophthalmol; 2021 Jan; 31(1):NP17-NP21. PubMed ID: 31137968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.
    Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.
    Lorenzo-Morales J; Morcillo-Laiz R; Martín-Navarro CM; López-Vélez R; López-Arencibia A; Arnalich-Montiel F; Maciver SK; Valladares B; Martínez-Carretero E
    Cont Lens Anterior Eye; 2011 Apr; 34(2):83-6. PubMed ID: 21130679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy].
    Chebbi CK; Kichenin K; Amar N; Nourry H; Warnet JM; Barritault D; Baudouin C
    J Fr Ophtalmol; 2008 May; 31(5):465-71. PubMed ID: 18641578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presumed late recurrence of Acanthamoeba keratitis exacerbated by exposure to topical corticosteroids.
    Patel DV; McGhee CNj
    Oman J Ophthalmol; 2013 Sep; 6(Suppl 1):S40-2. PubMed ID: 24391372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral miltefosine for refractory
    Hirabayashi KE; Lin CC; Ta CN
    Am J Ophthalmol Case Rep; 2019 Dec; 16():100555. PubMed ID: 31650083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Painless acanthamoeba keratitis].
    Roters S; Aisenbrey S; Severin M; Konen W; Seitz HM; Krieglstein GK
    Klin Monbl Augenheilkd; 2001 Aug; 218(8):570-3. PubMed ID: 11573159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of radial keratoneuritis in non-Acanthamoeba keratitis.
    Mutoh T; Matsumoto Y; Chikuda M
    Clin Ophthalmol; 2012; 6():1535-8. PubMed ID: 23055675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of regenerating agent plus cord blood serum eye drops for the treatment of resistant neurotrophic keratitis: a case report and a hypothesis for pathophysiologic mechanism.
    Giannaccare G; Fresina M; Vagge A; Versura P
    Int Med Case Rep J; 2015; 8():277-81. PubMed ID: 26586967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bilateral acanthamoeba keratitis].
    Holz FG; Burk RO; Völcker HE
    Klin Monbl Augenheilkd; 1993 Dec; 203(6):418-22. PubMed ID: 8145487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acanthamoeba keratitis and contact lens wear.
    Lindsay RG; Watters G; Johnson R; Ormonde SE; Snibson GR
    Clin Exp Optom; 2007 Sep; 90(5):351-60. PubMed ID: 17697181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical presentation of Acanthamoeba keratitis.
    Tabin G; Taylor H; Snibson G; Murchison A; Gushchin A; Rogers S
    Cornea; 2001 Oct; 20(7):757-9. PubMed ID: 11588431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acanthamoeba keratitis: about the first two Tunisian cases].
    Ben Salah S; Makni F; Cheikrouhou F; Ben Zina Z; Mlik M; Feki J; Colin J; Ayadi A
    Bull Soc Pathol Exot; 2007 Feb; 100(1):41-2. PubMed ID: 17402694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis.
    Rahimi F; Hashemian SM; Tafti MF; Mehjerdi MZ; Safizadeh MS; Pour EK; Sefidan BB
    J Ophthalmic Vis Res; 2015; 10(2):106-11. PubMed ID: 26425310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of corneal neurotrophic ulcers with Cacicol®-RGTA (ReGeneraTing Agent): a case series.
    Salazar-Quiñones L; Molero-Senosiáin M; Aguilar-Munoa S; Gegúndez-Fernández JA; Díaz-Valle D; Muñoz-Hernández AM; Benítez-Del-Castillo JM
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Sep; 95(9):421-428. PubMed ID: 32563627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.